We evaluated the alteration in the expression of the genes which are related to the angiogenesis in tumor bed following the management with antineoplstic agents to the various gynecologic cancer cell lines.
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direct effector to the VEGF, or bFGF in tumor vascular beds. Furthermore, cisplatin induced cytotoxicity was not developed in parallel with the alteration of expression of bFGF. Conclusion : These result suggest that ongoing research for the evaluation of antiangiogenetic effect with various cytotoxic agents, the objective tool should be proposed for the fine differentiation of the real antiangiogentic effect of cytotoxic and antiproliferating agent to endothelial cell., especially in the experiments with type 1 antiangiogenetic agent. In the case with type 2 antiangiogentic agents, iIt will be helpful to construct the condition with vector related transfection to the targeted cell lines, and to include various cytokines as a target to know the paracrine effects of the tumor cells in normal environment of the animal or other host. 
